1. Home
  2. REE vs VVOS Comparison

REE vs VVOS Comparison

Compare REE & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo REE Automotive Ltd.

REE

REE Automotive Ltd.

HOLD

Current Price

$0.60

Market Cap

17.1M

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$1.28

Market Cap

15.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REE
VVOS
Founded
2011
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1M
15.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
REE
VVOS
Price
$0.60
$1.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$11.75
$6.25
AVG Volume (30 Days)
49.8K
88.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.07
EPS
N/A
N/A
Revenue
N/A
$15,031,000.00
Revenue This Year
$327.73
$31.42
Revenue Next Year
$36,888.82
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.91
52 Week Low
$0.51
$1.28
52 Week High
$6.60
$7.40

Technical Indicators

Market Signals
Indicator
REE
VVOS
Relative Strength Index (RSI) 48.69 32.01
Support Level $0.53 N/A
Resistance Level $0.75 $1.88
Average True Range (ATR) 0.06 0.12
MACD 0.00 -0.00
Stochastic Oscillator 40.08 6.25

Price Performance

Historical Comparison
REE
VVOS

About REE REE Automotive Ltd.

REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: